.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Chinese Patent Office
McKesson
Queensland Health
Cerilliant
Chubb
US Department of Justice
McKinsey
Baxter
Mallinckrodt

Generated: July 25, 2017

DrugPatentWatch Database Preview

Poractant alfa - Generic Drug Details

« Back to Dashboard

What are the generic sources for poractant alfa and what is the scope of poractant alfa freedom to operate?

Poractant alfa
is the generic ingredient in one branded drug marketed by Chiesi Usa Inc and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for Generic Name: poractant alfa

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list1,253
Drug Prices:see low prices
DailyMed Link:poractant alfa at DailyMed

Pharmacology for Ingredient: poractant alfa

Drug ClassSurfactant
Mechanism of ActionSurfactant Activity
Physiological EffectAlveolar Surface Tension Reduction
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chiesi Usa Inc
CUROSURF
poractant alfa
SUSPENSION;INTRATRACHEAL020744-001Nov 18, 1999RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Mallinckrodt
US Department of Justice
Cipla
Dow
Julphar
Federal Trade Commission
Citi
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot